Mount Yale Investment Advisors, LLC Pacira Bio Sciences, Inc. Transaction History

Mount Yale Investment Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	SELL	$51.24 - $58.89 $2,459 - $2,826	-48 Reduced 1.26%	3,770 $201,000
Q2 2022 Aug 02, 2022	BUY	$51.49 - $81.64 $9,216 - $14,613	179 Added 4.92%	3,818 $223,000
Q1 2022 May 03, 2022	BUY	$60.03 - $76.49 $218,449 - $278,347	3,639 New	3,639 $278,000
Q4 2021 Feb 02, 2022	SELL	$47.97 - $62.21 $192,119 - $249,151	-4,005 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$54.64 - $61.3 $928 - $1,042	17 Added 0.43%	4,005 $224,000
Q2 2021 Aug 04, 2021	BUY	$59.18 - $69.99 $34,501 - $40,804	583 Added 17.12%	3,988 $242,000
Q1 2021 May 04, 2021	SELL	$59.31 - $78.82 $15,301 - $20,335	-258 Reduced 7.04%	3,405 $239,000
Q4 2020 Feb 12, 2021	BUY	$50.47 - $66.26 $184,871 - $242,710	3,663 New	3,663 $219,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Mount Yale Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mount Yale Investment Advisors, LLC with notifications on news.